Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 125832991 | 12583299 | 1 | I | 1990 | 20160718 | 20160722 | 20160722 | EXP | US-GLAXOSMITHKLINE-US2016GSK102678 | GLAXOSMITHKLINE | 0.00 | M | Y | 0.00000 | 20160722 | CN | US | US |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 125832991 | 12583299 | 1 | PS | WELLBUTRIN | BUPROPION HYDROCHLORIDE | 1 | UNK | 18644 | |||||||||||
| 125832991 | 12583299 | 2 | SS | WELLBUTRIN | BUPROPION HYDROCHLORIDE | 1 | 18644 | ||||||||||||
| 125832991 | 12583299 | 3 | SS | WELLBUTRIN | BUPROPION HYDROCHLORIDE | 1 | 18644 | ||||||||||||
| 125832991 | 12583299 | 4 | SS | XANAX | ALPRAZOLAM | 1 | 1 MG, QD | 0 | 1 | MG | QD | ||||||||
| 125832991 | 12583299 | 5 | SS | XANAX | ALPRAZOLAM | 1 | 2 MG, QID | 0 | 2 | MG | QID | ||||||||
| 125832991 | 12583299 | 6 | SS | XANAX | ALPRAZOLAM | 1 | 1 MG, TID | 0 | 1 | MG | TID | ||||||||
| 125832991 | 12583299 | 7 | SS | AMITRIPTYLINE | AMITRIPTYLINE | 1 | 25 MG, UNK | 0 | 25 | MG | |||||||||
| 125832991 | 12583299 | 8 | SS | AMITRIPTYLINE | AMITRIPTYLINE | 1 | 0 | ||||||||||||
| 125832991 | 12583299 | 9 | SS | AMITRIPTYLINE | AMITRIPTYLINE | 1 | 0 | ||||||||||||
| 125832991 | 12583299 | 10 | SS | TRILEPTAL | OXCARBAZEPINE | 1 | UNK | 0 | |||||||||||
| 125832991 | 12583299 | 11 | SS | METOPROLOL. | METOPROLOL | 1 | U | 0 |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 125832991 | 12583299 | 1 | Anxiety |
| 125832991 | 12583299 | 2 | Panic attack |
| 125832991 | 12583299 | 3 | Agoraphobia |
| 125832991 | 12583299 | 4 | Anxiety |
| 125832991 | 12583299 | 5 | Panic attack |
| 125832991 | 12583299 | 6 | Agoraphobia |
| 125832991 | 12583299 | 7 | Anxiety |
| 125832991 | 12583299 | 8 | Panic attack |
| 125832991 | 12583299 | 9 | Agoraphobia |
| 125832991 | 12583299 | 10 | Product used for unknown indication |
| 125832991 | 12583299 | 11 | Product used for unknown indication |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 125832991 | 12583299 | OT |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 125832991 | 12583299 | Abnormal behaviour | |
| 125832991 | 12583299 | Malaise | |
| 125832991 | 12583299 | Off label use | |
| 125832991 | 12583299 | Performance status decreased | |
| 125832991 | 12583299 | Seizure |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
|---|---|---|---|---|---|---|
| 125832991 | 12583299 | 1 | 1990 | 0 | ||
| 125832991 | 12583299 | 4 | 1990 | 0 | ||
| 125832991 | 12583299 | 5 | 2001 | 0 |